Companies › Syndex Bio
Syndex Bio logo

Syndex Bio

Cambridge, UK · syndex.bio

Syndex Bio is a biotechnology platform offering molecular technologies and AI for the diagnosis and treatment of disease.

Funding

1
Every round, secondary, debt facility or acquisition involving Syndex Bio that Lounge tracks, newest first. Latest: Seed on Feb 23, 2026.

Timeline · 1

Feb 23, 2026
Round
Seed · $15.5M at $61M · Arch Venture Partners
Paid members see every AI company on Lounge with revenue, funding, valuation and investors, searchable and sortable, plus CSV exports. Plans start at $19/mo.
See plans →Log in